Analyst firms · Wolfe Research · LIVN
Wolfe Research LIVN price target and rating history
LivaNova PLC (LIVN) · Health Care
Wolfe Research rates LivaNova PLC (LIVN) Outperform with a $60 price target, as of its latest action on May 20, 2025. It has published 3 rating actions on LIVN since April 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Outperform
- Price target
- $60
- Median target, all firms
- Too few
- Actions on LIVN
- 3
Wolfe Research price target on LIVN
Every Wolfe Research rating on LIVN
- May 20, 2025
- Feb 26, 2025
- Apr 6, 2022
How other firms rate LIVN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Overweight | $105 | Oct 7, 2026 |
| KeyBanc Capital Markets | Overweight | $81 | Dec 19, 2025 |
Questions about Wolfe Research and LIVN
- What is Wolfe Research's price target for LIVN?
- Wolfe Research's latest stated price target for LivaNova PLC (LIVN) is $60, from its action on May 20, 2025.
- What is Wolfe Research's rating on LIVN?
- Wolfe Research rates LIVN Outperform, a bullish rating, as of May 20, 2025.
- When did Wolfe Research last change its view on LIVN?
- On May 20, 2025, Wolfe Research upgrades to Outperform from Peer Perform, price target $60.
More LIVN rating histories
All Wolfe Research ratingsLIVN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.